{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:09:34Z","timestamp":1789927774012,"version":"4.0.1"},"reference-count":46,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2018,12,1]]},"DOI":"10.1001\/jamaoncol.2018.4154","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T03:34:24Z","timestamp":1538710464000},"page":"1683","source":"Crossref","is-referenced-by-count":185,"title":["Association Between Aspirin Use and Risk of Hepatocellular Carcinoma"],"prefix":"10.1001","volume":"4","author":[{"given":"Tracey G.","family":"Simon","sequence":"first","affiliation":[{"name":"Liver Center, Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, School of Public Health, China Medical University, Shenyang, Liaoning, PR China"},{"name":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas F.","family":"Ludvigsson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Karolinska University Hospital, Stockholm, Sweden"},{"name":"Department of Pediatrics, \u00d6rebro University Hospital, \u00d6rebro, Sweden"},{"name":"Columbia University College of Physicians and Surgeons, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn Q.","family":"Chong","sequence":"additional","affiliation":[{"name":"National Cancer Centre Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L.","family":"Giovannucci","sequence":"additional","affiliation":[{"name":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Fuchs","sequence":"additional","affiliation":[{"name":"Yale University Cancer Center, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Meyerhardt","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Corey","sequence":"additional","affiliation":[{"name":"Liver Center, Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Department of Biostatistics and Epidemiology, School of Public Health, China Medical University, Shenyang, Liaoning, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond T.","family":"Chung","sequence":"additional","affiliation":[{"name":"Liver Center, Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Chan","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Broad Institute, Boston, Massachusetts"},{"name":"Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"coi180078r1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"issue":"1","key":"coi180078r2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012.","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"coi180078r3","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma.","volume":"365","author":"El-Serag","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"coi180078r4","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1053\/j.gastro.2016.11.020","article-title":"Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012.","volume":"152","author":"White","year":"2017","journal-title":"Gastroenterology"},{"issue":"9","key":"coi180078r5","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/cncr.v122.9","article-title":"Annual report to the nation on the status of cancer, 1975-2012, featuring the increasing incidence of liver cancer.","volume":"122","author":"Ryerson","year":"2016","journal-title":"Cancer"},{"issue":"31","key":"coi180078r6","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1038\/onc.2017.73","article-title":"Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice.","volume":"36","author":"Chen","year":"2017","journal-title":"Oncogene"},{"issue":"4, pt 1","key":"coi180078r7","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1053\/jhep.2002.36125","article-title":"Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells.","volume":"36","author":"Kern","year":"2002","journal-title":"Hepatology"},{"key":"coi180078r8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1196\/annals.1322.052","article-title":"Induction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors.","volume":"1028","author":"Foder\u00e0","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"23","key":"coi180078r9","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1093\/jnci\/djs452","article-title":"Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.","volume":"104","author":"Sahasrabuddhe","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"coi180078r10","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1158\/1940-6207.CAPR-15-0126","article-title":"NSAID use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: the Liver Cancer Pooling Project.","volume":"8","author":"Petrick","year":"2015","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"coi180078r11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrgastro.2013.143","article-title":"Chemopreventive strategies in hepatocellular carcinoma.","volume":"11","author":"Singh","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"23","key":"coi180078r12","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1093\/jnci\/djs462","article-title":"An aspirin a day: the allure (and distraction) of chemoprevention.","volume":"104","author":"Levy","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"coi180078r13","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.2147\/OTT","article-title":"The effects of nonsteroidal anti-inflammatory drugs in the incident and recurrent risk of hepatocellular carcinoma: a meta-analysis.","volume":"10","author":"Pang","year":"2017","journal-title":"Onco Targets Ther"},{"issue":"1","key":"coi180078r14","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1038\/s41598-018-23343-0","article-title":"Aspirin use and risk of hepatocellular carcinoma in a national cohort study of Korean Adults.","volume":"8","author":"Hwang","year":"2018","journal-title":"Sci Rep"},{"issue":"5","key":"coi180078r15","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/oxfordjournals.aje.a114319","article-title":"Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women.","volume":"123","author":"Colditz","year":"1986","journal-title":"Am J Epidemiol"},{"issue":"1","key":"coi180078r16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/00001648-199601000-00014","article-title":"Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals.","volume":"7","author":"Chasan-Taber","year":"1996","journal-title":"Epidemiology"},{"issue":"1","key":"coi180078r17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/oxfordjournals.aje.a114086","article-title":"Reproducibility and validity of a semiquantitative food frequency questionnaire.","volume":"122","author":"Willett","year":"1985","journal-title":"Am J Epidemiol"},{"issue":"4","key":"coi180078r18","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1093\/ije\/18.4.858","article-title":"Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption.","volume":"18","author":"Salvini","year":"1989","journal-title":"Int J Epidemiol"},{"issue":"6","key":"coi180078r19","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/oxfordjournals.aje.a115598","article-title":"Effectiveness of various mailing strategies among nonrespondents in a prospective cohort study.","volume":"131","author":"Rimm","year":"1990","journal-title":"Am J Epidemiol"},{"issue":"1","key":"coi180078r20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/j.gastro.2007.09.035","article-title":"Aspirin dose and duration of use and risk of colorectal cancer in men.","volume":"134","author":"Chan","year":"2008","journal-title":"Gastroenterology"},{"issue":"6","key":"coi180078r21","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/archinte.167.6.562","article-title":"Long-term aspirin use and mortality in women.","volume":"167","author":"Chan","year":"2007","journal-title":"Arch Intern Med"},{"issue":"5","key":"coi180078r22","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1002\/hep.v67.5","article-title":"Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies.","volume":"67","author":"Simon","year":"2018","journal-title":"Hepatology"},{"issue":"11","key":"coi180078r23","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/oxfordjournals.aje.a117191","article-title":"Test of the National Death Index and Equifax Nationwide Death Search.","volume":"140","author":"Rich-Edwards","year":"1994","journal-title":"Am J Epidemiol"},{"issue":"6","key":"coi180078r24","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3945\/jn.111.157222","article-title":"Alternative dietary indices both strongly predict risk of chronic disease.","volume":"142","author":"Chiuve","year":"2012","journal-title":"J Nutr"},{"key":"coi180078r25","doi-asserted-by":"publisher","first-page":"h4238","DOI":"10.1136\/bmj.h4238","article-title":"Light to moderate intake of alcohol, drinking patterns, and risk of cancer: results from two prospective US cohort studies.","volume":"351","author":"Cao","year":"2015","journal-title":"BMJ"},{"issue":"21","key":"coi180078r26","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1056\/NEJMoa067208","article-title":"Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.","volume":"356","author":"Chan","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"coi180078r27","first-page":"1393","article-title":"COX-2 overexpression increases motility and invasion of breast cancer cells.","volume":"26","author":"Singh","year":"2005","journal-title":"Int J Oncol"},{"issue":"2","key":"coi180078r28","first-page":"519","article-title":"Increased expression of cyclooxygenase-2 protein in human gastric carcinoma.","volume":"6","author":"Lim","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"2","key":"coi180078r29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/carcin\/21.2.139","article-title":"Cyclooxygenase-2 expression in human pancreatic adenocarcinomas.","volume":"21","author":"Yip-Schneider","year":"2000","journal-title":"Carcinogenesis"},{"issue":"22","key":"coi180078r30","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis.","volume":"353","author":"Patrono","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"coi180078r31","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1073\/pnas.95.2.681","article-title":"Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis.","volume":"95","author":"Chan","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"coi180078r32","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1053\/jhep.2003.50380","article-title":"Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis.","volume":"38","author":"Leng","year":"2003","journal-title":"Hepatology"},{"issue":"5","key":"coi180078r33","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.5114\/aoms.2016.61916","article-title":"Prognostic significance of cyclooxygenase-2 expression in patients with hepatocellular carcinoma: a meta-analysis.","volume":"12","author":"Chen","year":"2016","journal-title":"Arch Med Sci"},{"issue":"6","key":"coi180078r34","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jamaoncol.2015.6396","article-title":"Population-wide impact of long-term use of aspirin and the risk for cancer.","volume":"2","author":"Cao","year":"2016","journal-title":"JAMA Oncol"},{"issue":"9","key":"coi180078r35","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/apt.2014.40.issue-9","article-title":"Association between aspirin use and the prevalence of nonalcoholic fatty liver disease: a cross-sectional study from the Third National Health and Nutrition Examination Survey.","volume":"40","author":"Shen","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"coi180078r36","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/apt.2016.43.issue-6","article-title":"Aspirin use is associated with lower indices of liver fibrosis among adults in the United States.","volume":"43","author":"Jiang","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"coi180078r37","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1002\/hep.29318","article-title":"Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment.","volume":"66","author":"Lee","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"coi180078r38","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.amjmed.2010.12.022","article-title":"Long-term use of aspirin and the risk of gastrointestinal bleeding.","volume":"124","author":"Huang","year":"2011","journal-title":"Am J Med"},{"issue":"6","key":"coi180078r39","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1586\/ecp.10.120","article-title":"Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity.","volume":"3","author":"Knights","year":"2010","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"23","key":"coi180078r40","doi-asserted-by":"publisher","first-page":"7330","DOI":"10.1021\/bi952776w","article-title":"Synthesis and use of iodinated nonsteroidal antiinflammatory drug analogs as crystallographic probes of the prostaglandin H2 synthase cyclooxygenase active site.","volume":"35","author":"Loll","year":"1996","journal-title":"Biochemistry"},{"issue":"2","key":"coi180078r41","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/01926230600611752","article-title":"NSAID-induced acute phase response is due to increased intestinal permeability and characterized by early and consistent alterations in hepatic gene expression.","volume":"34","author":"Tugendreich","year":"2006","journal-title":"Toxicol Pathol"},{"key":"coi180078r42","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1038\/oncsis.2015.49","article-title":"Lipid metabolic reprogramming in cancer cells.","volume":"5","author":"Beloribi-Djefaflia","year":"2016","journal-title":"Oncogenesis"},{"issue":"1","key":"coi180078r43","doi-asserted-by":"publisher","first-page":"16978","DOI":"10.1038\/s41598-017-17285-2","article-title":"Peretinoin, an acyclic retinoid, inhibits hepatocarcinogenesis by suppressing sphingosine kinase 1 expression in vitro and in vivo.","volume":"7","author":"Funaki","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"coi180078r44","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.bbrc.2017.04.100","article-title":"Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK\/IGF-1R signalling.","volume":"487","author":"Grbcic","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"coi180078r45","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jhep.2017.09.016","article-title":"Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.","volume":"68","author":"Fujiwara","year":"2018","journal-title":"J Hepatol"},{"issue":"4","key":"coi180078r46","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/jama.1991.03470040085027","article-title":"A prospective study of aspirin use and primary prevention of cardiovascular disease in women.","volume":"266","author":"Manson","year":"1991","journal-title":"JAMA"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaoncology\/article-pdf\/4\/12\/1683\/17357283\/jamaoncology_simon_2018_oi_180078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T11:03:52Z","timestamp":1551956632000},"score":1,"resource":{"primary":{"URL":"http:\/\/oncology.jamanetwork.com\/article.aspx?doi=10.1001\/jamaoncol.2018.4154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2018.4154","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,1]]}}}